These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23149054)

  • 1. On cardiovascular risk estimation in patients with psoriasis: The REGICOR and SCORE scales.
    Labandeira García J; Alonso-González J
    Actas Dermosifiliogr; 2012 Dec; 103(10):942-3; discussion 943-4. PubMed ID: 23149054
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the framingham risk score in patients with chronic psoriasis.
    Gisondi P; Farina S; Giordano MV; Girolomoni G
    Am J Cardiol; 2010 Dec; 106(12):1754-7. PubMed ID: 21055711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis and cardiovascular risk. Assessment by different cardiovascular risk scores.
    Fernández-Torres R; Pita-Fernández S; Fonseca E
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1566-70. PubMed ID: 22731956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and vascular risk estimation in a Mediterranean non-diabetic population without cardiovascular disease.
    Jansen-Chaparro S; Mancera J; Cuende JI; Villalobos A; Baca AJ; Lopez-Carmona MD; Bernal-Lopez MR; Tinahones FJ; Gomez-Huelgas R
    Eur J Intern Med; 2012 Sep; 23(6):558-63. PubMed ID: 22863435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular morbidity, risk of cancer and alcohol abuse in psoriasis: systematic literature reviews and expert opinion.
    Richard MA; Paul C
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():1. PubMed ID: 23845147
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular risk and psoriasis: a role in clinical cardiology?
    Imbalzano E; Casale M; D'Angelo M; Mandraffino G; Giugno V; Di Bella G; Carerj S; Dattilo G
    Angiology; 2015 Feb; 66(2):101-3. PubMed ID: 24671131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psoriasis and atherothrombotic disease].
    Ahlehoff O; Gislason GH; Skov L; Hansen PR
    Ugeskr Laeger; 2010 Jun; 172(26):1983-6. PubMed ID: 20654288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and psoriasis: the role of biologic therapy.
    Puig L
    Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
    Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients with psoriasis have an increased risk of cardiovascular diseases].
    Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR
    Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts.
    Volf EM; Levine DE; Michelon MA; Au SC; Patvardhan E; Dumont N; Loo DS; Kuvin J; Gottlieb AB
    J Drugs Dermatol; 2011 Aug; 10(8):900-1. PubMed ID: 21818512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
    Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
    Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psoriasis and cardiovascular risk factors].
    Tal R; Pavlovsky L; David M
    Harefuah; 2012 Oct; 151(10):573-5, 605. PubMed ID: 23316664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
    Kaye JA; Li L; Jick SS
    Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart disease in psoriasis.
    Kremers HM; McEvoy MT; Dann FJ; Gabriel SE
    J Am Acad Dermatol; 2007 Aug; 57(2):347-54. PubMed ID: 17433490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.